speb/financial-data huggingface dataset:
Stock screener scorecard for LYKALABS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.684873936238924 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.494102319847585%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.042520880789674%
Revenue growth: -13.215344830088432%
Rule of 40 score: -13.215344830088432
Market cap: 2260628992 (Mid Cap ($2B-$10B))
Debt to equity: 0.5380176899178039
Operating income: -900370.9198813057
Net income: -806146.6723187792
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for MBWS.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 326645376 (Small Cap ($300M-$2B))
P/E ratio: 41.911764705882355
Debt to equity: 0.030600000000000002
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for MGAM.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 621933312 (Small Cap ($300M-$2B))
Debt to equity: 1.0338
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MHC.AX (annual, report date 2024-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -27.695658733252763%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -13.517261427326629%
Rule of 40 score: 0
Market cap: 15880363 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1661842
Operating income: -1111030.6666666667
Net income: -1085923.3333333333
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for MPK.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 135022688 (Micro Cap ($50M-$300M))
Debt to equity: 0.0012
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NFG.V (quarterly, report date 2026-03-31)
Altman Z-score: 2.932255379691172 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.753415398932136%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.5977086796233397%
Free cash flow margin: -264.6301528879595%
Revenue growth: 67.82509715710219%
Rule of 40 score: -196.80505573085733
Market cap: 760483456 (Small Cap ($300M-$2B))
Debt to equity: 0.0042
Free cash flow (dilution adjusted): -18824587.769784175
Operating income: -12943546.76258993
Net income: -13747522.302158274
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for OGS (quarterly, report date 2026-03-31)
Altman Z-score: 0.8127863106505877 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.4715684994954494%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5540051413646263%
Free cash flow margin: 1.5926205136159075%
Revenue growth: 20.647632918076162%
Rule of 40 score: 22.24025343169207
Market cap: 5054266880 (Mid Cap ($2B-$10B))
P/E ratio: 19.28216704288939
Debt to equity: 0.9590000000000001
Free cash flow (dilution adjusted): 13246000
Operating income: 189592000
Net income: 128673000
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ORTINGLOBE.NS (annual, report date 2026-03-31)
Altman Z-score: 1.9982157101652842 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -62.96176541912537%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -32.166272690780964%
Free cash flow margin: -556.81592039801%
Revenue growth: -73.37636379717901%
Rule of 40 score: -630.192284195189
Market cap: 120425920 (Micro Cap ($50M-$300M))
Debt to equity: 0.8123999999999999
Free cash flow (dilution adjusted): -59304.79016532429
Operating income: -76430.69097075032
Net income: -78465.45146248411
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ORTINGLOBE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.4906520158977683 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.727507881335381%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3434280362160475%
Revenue growth: 166.07043772854004%
Rule of 40 score: 166.07043772854004
Market cap: 120425920 (Micro Cap ($50M-$300M))
Debt to equity: 0.8123999999999999
Operating income: -816.0237388724036
Net income: -985.5871131835523
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for PGN.DE (quarterly, report date 2025-09-30)
Altman Z-score: -0.3994029731847344 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.291062092008787%
Free cash flow margin: -9.201001749631203%
Revenue growth: -5.510713475315245%
Rule of 40 score: -14.711715224946449
Market cap: 7490970 (Nano Cap (< $50M))
Debt to equity: -8.102446112860262
Free cash flow (dilution adjusted): -3155294.117647059
Operating income: 1631764.705882353
Net income: -448235.29411764705
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for QFIN (quarterly, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.7844403959549013%
Capitalized R&D asset: 0
Free cash flow margin: 69.66666544873927%
Revenue growth: -10.53774632503483%
Rule of 40 score: 59.128919123704435
Market cap: 1605907328 (Small Cap ($300M-$2B))
P/E ratio: 2.140597539543058
Debt to equity: 0.1168
Free cash flow (dilution adjusted): 303526772.79305357
Net income: 127832706.2228654
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RKH.L (annual, report date 2025-12-31)
Altman Z-score: 1.5566765949503056 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.439087822172556%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.898447325239248%
Rule of 40 score: 0
Market cap: 629317824 (Small Cap ($300M-$2B))
Debt to equity: 0.061799999999999994
Free cash flow (dilution adjusted): 31267567.567567565
Operating income: -107624324.32432432
Net income: -53622972.972972974
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for RKH.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 629317824 (Small Cap ($300M-$2B))
Debt to equity: 0.061799999999999994
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RMI (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 97817304 (Micro Cap ($50M-$300M))
P/E ratio: 115.16666666666667
Debt to equity: 0.6610406139021732
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for RNTX (quarterly, report date 2026-03-31)
Altman Z-score: -22.030965352755366 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 4968400
ROCI (R&D adjusted): -25.02166172892758%
Rule of 40 score: 0
Market cap: 67687032 (Micro Cap ($50M-$300M))
Debt to equity: 0.42469999999999997
Free cash flow (dilution adjusted): -3580000
Operating income: -5230000
Net income: -5838000
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for SANGAMIND.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: -3.1080689572486393%
Rule of 40 score: -3.1080689572486393
Market cap: 30367571968 (Large Cap ($10B-$200B))
P/E ratio: 0.23725782700166265
Debt to equity: 1.1874
Operating income: 8409114.885536449
Net income: 4327460.70260576
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SHEMAROO.NS (annual, report date 2026-03-31)
Altman Z-score: 0.37489635364125634 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -80.9157295396117%
Capitalized R&D asset: 155311.52831175932
ROCI (R&D adjusted): -96.15701167835627%
Rosenberg metric: -329.24871553302444
Free cash flow margin: 3.038019933559412%
Revenue growth: -23.029296373201056%
Rule of 40 score: -19.991276439641645
Market cap: 3487283712 (Mid Cap ($2B-$10B))
Debt to equity: 1.1291
Free cash flow (dilution adjusted): 1862547.6896990251
Operating income: -28348124.205171682
Net income: -23119203.05214074
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for SHEMAROO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.5954424643204184 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.49142334409593%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -32.00821867245109%
Revenue growth: -17.41516733775583%
Rule of 40 score: -17.41516733775583
Market cap: 3487283712 (Mid Cap ($2B-$10B))
Debt to equity: 1.1291
Operating income: -9392210.682492582
Net income: -7627490.462060195
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for TOO.L (annual, report date 2025-12-31)
Altman Z-score: -0.6270385410086265 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.645933014354066%
Free cash flow margin: 16.387865041111425%
Rule of 40 score: 16.387865041111425
Market cap: 3723821 (Nano Cap (< $50M))
Debt to equity: 30.83108108108108
Free cash flow (dilution adjusted): 1562162.1621621621
Operating income: -883783.7837837838
Net income: -2395945.945945946
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for TOO.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3723821 (Nano Cap (< $50M))
Debt to equity: 30.83108108108108
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for UHR.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8834123776 (Mid Cap ($2B-$10B))
P/E ratio: 1224.8696947133283
Debt to equity: 0.020499999999999997
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VVTM.V (quarterly, report date 2026-03-31)
Altman Z-score: -44.76812008541842 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 112492.56859155718
Rosenberg metric: 0.0949367088607595
Free cash flow margin: -125.92592592592592%
Revenue growth: 2617.0886075949365%
Rule of 40 score: 2491.1626816690105
Market cap: 14076951 (Nano Cap (< $50M))
Debt to equity: -0.46446917808219174
Free cash flow (dilution adjusted): -21518.98734177215
Operating income: -176265.82278481012
Net income: -176265.82278481012
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for WATR.V (quarterly, report date 2025-09-30)
Altman Z-score: -43.14981998763551 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: 5.187821438062434%
Revenue growth: -33.10190149800983%
Rule of 40 score: -27.914080059947395
Market cap: 2465900 (Nano Cap (< $50M))
Debt to equity: -0.9126132064111745
Free cash flow (dilution adjusted): 7162.589928057554
Operating income: -152523.74100719424
Net income: -159732.37410071943
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for XELPMOC.NS (annual, report date 2026-03-31)
Altman Z-score: 6.5255546523725405 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.08118144241538%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.751769263798366%
Free cash flow margin: -218.10620618535728%
Revenue growth: -13.140627218767511%
Rule of 40 score: -231.2468334041248
Market cap: 1201570816 (Small Cap ($300M-$2B))
Debt to equity: 0.0092
Free cash flow (dilution adjusted): -863395.9304790165
Operating income: -862987.8126324714
Net income: -804660.6612971599
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for XELPMOC.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.730648034040109 (Safe Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.116971406903662%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.4156150400041962%
Revenue growth: -7.939254220578216%
Rule of 40 score: -7.939254220578216
Market cap: 1201570816 (Small Cap ($300M-$2B))
Debt to equity: 0.0092
Operating income: -213771.08944467996
Net income: -188549.3853327681
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for ZONE (quarterly, report date 2026-03-31)
Altman Z-score: 9.866833486793476 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -274.2765429206045%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -28.347908062290312%
Free cash flow margin: -1550.8499266131316%
Revenue growth: -49.13285387766864%
Rule of 40 score: -1599.9827804908002
Market cap: 159529648 (Micro Cap ($50M-$300M))
Debt to equity: 0.0052
Free cash flow (dilution adjusted): -8431878
Operating income: -18979869
Net income: -37264986
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for 0932.HK (annual, report date 2025-03-31)
Altman Z-score: -0.8954928746793874 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.151271753681396%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.3879118502654393%
Free cash flow margin: 11.540712418555655%
Revenue growth: -12.40320341485283%
Rule of 40 score: -0.8624909962971756
Market cap: 62157868.8 (Micro Cap ($50M-$300M))
Debt to equity: 0.9525213343677268
Free cash flow (dilution adjusted): 3041645.2442159383
Operating income: 439974.29305912595
Net income: -4658483.290488432
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 2391.T (annual, report date 2025-07-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8235747878.5 (Mid Cap ($2B-$10B))
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 5582.T (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12170391120.000002 (Large Cap ($10B-$200B))
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7265.T (annual, report date 2025-10-31)
Altman Z-score: 3.1375957274947552 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.203523455693368%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.46130150294289%
Free cash flow margin: 6.327330701765432%
Revenue growth: 10.684586124800221%
Rule of 40 score: 17.011916826565653
Market cap: 3360287840 (Mid Cap ($2B-$10B))
P/E ratio: 10.290806258479238
Debt to equity: 0.07753755316791434
Free cash flow (dilution adjusted): 3330220.922677063
Operating income: 2671838.85640026
Net income: 2121721.897335932
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for AGIO (annual, report date 2025-12-31)
Altman Z-score: 8.359163648253357 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -34.52478137043066%
Capitalized R&D asset: 638920200
ROCI (R&D adjusted): -23.98744611833369%
Rosenberg metric: 0.05094826842269472
Free cash flow margin: -814.1056489227808%
Revenue growth: 48.030029042687275%
Rule of 40 score: -766.0756198800935
Market cap: 1618817196.98 (Small Cap ($300M-$2B))
Debt to equity: 0.03369921063703887
Free cash flow (dilution adjusted): -439845000
Operating income: -472132000
Net income: -412781000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for ALAGP.PA (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12584807.040000001 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ALPJT.PA (annual, report date 2025-03-31)
Altman Z-score: 1.6785789991815827 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.5946202698661257%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.379923280566211%
Free cash flow margin: 3.362690840515079%
Revenue growth: 0.1330271282890228%
Rule of 40 score: 3.495717968804102
Market cap: 79486140.24 (Micro Cap ($50M-$300M))
P/E ratio: 43.245995778019584
Debt to equity: 0.7895537489475211
Free cash flow (dilution adjusted): 12753260.869565217
Operating income: 5745652.173913043
Net income: 1997826.0869565217
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ALPRI.PA (annual, report date 2025-03-31)
Altman Z-score: 2.0264136470204996 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 78.2400403429148%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.597893396608598%
Free cash flow margin: 3.480510960876141%
Revenue growth: 7.259400085915782%
Rule of 40 score: 10.739911046791924
Market cap: 8138388.000000001 (Nano Cap (< $50M))
P/E ratio: 6.670809836065574
Debt to equity: 0.5785299806576402
Free cash flow (dilution adjusted): 2076086.956521739
Operating income: 2178260.8695652173
Net income: 1326086.956521739
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for BLDS.V (annual, report date 2025-03-31)
Altman Z-score: -108.40439112849288 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1938388.2 (Nano Cap (< $50M))
Debt to equity: -0.2056838824358293
Free cash flow (dilution adjusted): -186046.15384615384
Operating income: -701158.7412587412
Net income: -8232039.160839161
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BRSP (annual, report date 2025-12-31)
Altman Z-score: 0.4198024000641093 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8773291675766834%
Free cash flow margin: 18.66111484883905%
Revenue growth: -7.107679369614303%
Rule of 40 score: 11.553435479224746
Market cap: 687868183.2 (Small Cap ($300M-$2B))
Debt to equity: 2.6826783569670565
Free cash flow (dilution adjusted): 60189000
Operating income: 30007000
Net income: -31148000
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for EMR.V (annual, report date 2025-12-31)
Altman Z-score: -27.390167661758426 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.681220966324362%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -46.14241002129107%
Rule of 40 score: 0
Market cap: 3391769.6 (Nano Cap (< $50M))
P/E ratio: 12.309893587677657
Debt to equity: 0.5215776583004499
Free cash flow (dilution adjusted): -490288.3211678832
Operating income: -467138.68613138684
Net income: 201118.24817518247
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for FLX (annual, report date 2025-12-31)
Altman Z-score: 2.809032949710007 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.30636907832761%
Capitalized R&D asset: 29487320.77253999
ROCI (R&D adjusted): 2.5429690565045937%
Rosenberg metric: -0.00945221014665493
Free cash flow margin: 1.3142564992020425%
Revenue growth: -6.826195705251313%
Rule of 40 score: -5.51193920604927
Market cap: 1289684676.42 (Small Cap ($300M-$2B))
P/E ratio: 11.78558404463168
Debt to equity: 0.027060413417330297
Free cash flow (dilution adjusted): 7495142.857142857
Operating income: 6614428.571428572
Net income: 15632714.285714285
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for HGBL (annual, report date 2025-12-31)
Altman Z-score: -1.3156270203711231 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.59142052199798%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.665084634166415%
Free cash flow margin: -6.34195143002864%
Revenue growth: 12.382883975221006%
Rule of 40 score: 6.040932545192366
Market cap: 43071094.96 (Nano Cap (< $50M))
P/E ratio: 12.00755365486479
Debt to equity: 0.08537987250496394
Free cash flow (dilution adjusted): -3233000
Operating income: 5588000
Net income: 3587000
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for HNRG (annual, report date 2025-12-31)
Altman Z-score: 3.557865213995095 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 50.01157458096889%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 22.926901832445363%
Free cash flow margin: 1.78713687466185%
Revenue growth: 16.158739505986507%
Rule of 40 score: 17.945876380648357
Market cap: 897362663.68 (Small Cap ($300M-$2B))
P/E ratio: 21.4316033455136
Debt to equity: 0.24041968804940156
Free cash flow (dilution adjusted): 8390000
Operating income: 58567000
Net income: 41871000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for INVE (annual, report date 2025-12-31)
Altman Z-score: 2.637030509715862 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.841422591168506%
Capitalized R&D asset: 7333960
ROCI (R&D adjusted): -14.200801422170203%
Rosenberg metric: 0.24877797787496783
Free cash flow margin: -51.2614038354124%
Revenue growth: -19.31801111611837%
Rule of 40 score: -70.57941495153077
Market cap: 92183854.08 (Micro Cap ($50M-$300M))
Debt to equity: 0.00608382314269266
Free cash flow (dilution adjusted): -11013000
Operating income: -20622000
Net income: -18003000
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for IPW (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 293657306.16 (Micro Cap ($50M-$300M))
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NFG.V (annual, report date 2025-12-31)
Altman Z-score: 6.847907380049729 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.778873122922295%
Capitalized R&D asset: 652020.9510489511
ROCI (R&D adjusted): -11.617682285274064%
Rosenberg metric: 0.17348279718637719
Free cash flow margin: -1114.0441155831104%
Rule of 40 score: -1114.0441155831104
Market cap: 1559375148.9399996 (Small Cap ($300M-$2B))
Debt to equity: 0.002723344012358182
Free cash flow (dilution adjusted): -47220613.86861314
Operating income: -43214384.67153285
Net income: -34724540.1459854
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for OGS (annual, report date 2025-12-31)
Altman Z-score: 1.0337471314515936 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.12500524868258%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.248502641497476%
Free cash flow margin: -5.898588959178192%
Revenue growth: 16.50398021077407%
Rule of 40 score: 10.60539125159588
Market cap: 4769952508 (Mid Cap ($2B-$10B))
P/E ratio: 18.05268449497396
Debt to equity: 0.9806852836366606
Free cash flow (dilution adjusted): -143184000
Operating income: 457467000
Net income: 264224000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for PGN.DE (annual, report date 2024-12-31)
Altman Z-score: 0.8976916134162607 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 24.605951654842546%
Free cash flow margin: 3.7379614911567756%
Revenue growth: -24.9653519351106%
Rule of 40 score: -21.227390443953826
Market cap: 8780956.040000001 (Nano Cap (< $50M))
Debt to equity: -6.96794936200141
Free cash flow (dilution adjusted): 5413541.666666667
Operating income: 7984375
Net income: -6359375
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for QFIN (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 25.19120632563101%
Capitalized R&D asset: 0
Free cash flow margin: 65.07265433410734%
Revenue growth: 19.469590027212412%
Rule of 40 score: 84.54224436131975
Market cap: 15494144757.84 (Large Cap ($10B-$200B))
P/E ratio: 2.586802016638254
Debt to equity: 0.1582805892260903
Free cash flow (dilution adjusted): 1494976000
Net income: 855670142.8571428
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for RMI (annual, report date 2025-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.050344289142082%
Capitalized R&D asset: 0
Revenue growth: -354.6076897531934%
Rule of 40 score: -354.6076897531934
Market cap: 84335150.97 (Micro Cap ($50M-$300M))
Debt to equity: 0.6331343816767013
Free cash flow (dilution adjusted): 9038672
Net income: -3991909
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for RNTX (annual, report date 2025-12-31)
Altman Z-score: -25.202729505554142 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 21892190
ROCI (R&D adjusted): -51.813146614049245%
Rule of 40 score: 0
Market cap: 99225277.11999999 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -21585000
Operating income: -21931000
Net income: -49871000
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for VVTM.V (annual, report date 2025-12-31)
Altman Z-score: -47.71511921036694 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 220456.96529099654
Rosenberg metric: 0.39917696104455125
Free cash flow margin: -3556.1797752808984%
Revenue growth: 19.719613061906053%
Rule of 40 score: -3536.4601622189925
Market cap: 46678523.64963504 (Nano Cap (< $50M))
Debt to equity: -0.5802197802197802
Free cash flow (dilution adjusted): -995283.0188679245
Operating income: -1551886.7924528301
Net income: -1250314.465408805
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for WATR.V (annual, report date 2024-12-31)
Altman Z-score: -26.766529946557174 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -256.6299898979618%
Free cash flow margin: -34.23941326447012%
Revenue growth: -30.20018843794368%
Rule of 40 score: -64.4396017024138
Market cap: 6868251.12 (Nano Cap (< $50M))
Debt to equity: -5.723055881203598
Free cash flow (dilution adjusted): -365315.3846153846
Operating income: -723030.7692307692
Net income: -712088.8111888112
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ZONE (annual, report date 2025-06-30)
Altman Z-score: 41.79166879510976 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -113.65046038791782%
Free cash flow margin: -268.87237472947663%
Revenue growth: 29.150708454285525%
Rule of 40 score: -239.7216662751911
Market cap: 539311420.08 (Small Cap ($300M-$2B))
Debt to equity: 3.686033662077706
Free cash flow (dilution adjusted): -5573278
Operating income: -6386341
Net income: -6742275
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for HSLV (annual, report date 2025-09-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.804162988405404%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -11.739025023425743%
Rule of 40 score: 0
Market cap:  (Unknown)
Debt to equity: 0
Free cash flow (dilution adjusted): -6623185.7050359715
Operating income: -6789867.316546763
Net income: -6765961.798561152
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for SUUN (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap:  (Unknown)
Debt to equity: 3.822570850202428
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0030.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2356990720 (Mid Cap ($2B-$10B))
Debt to equity: 0.0227
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0030.HK (annual, report date 2025-12-31)
Altman Z-score: 6.427569648691904 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.627884160783643%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.198976268315327%
Free cash flow margin: -9.027241445638941%
Revenue growth: 46.414553555108014%
Rule of 40 score: 37.38731210946907
Market cap: 2356990720 (Mid Cap ($2B-$10B))
P/E ratio: 494.0385830395398
Debt to equity: 0.0227
Free cash flow (dilution adjusted): -12858325.449871466
Operating income: 1027398.0719794345
Net income: 588692.6735218508
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 0318.HK (quarterly, report date 2025-10-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 256550400 (Micro Cap ($50M-$300M))
P/E ratio: 1.287001287001287
Debt to equity: 0.0701
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 0347.HK (quarterly, report date 2026-03-31)
Altman Z-score: 0.003333742194922107 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.471222127048161%
Capitalized R&D asset: 27453675.83212735
ROCI (R&D adjusted): -2.2109132069321293%
Rosenberg metric: 4.999233846939644
Free cash flow margin: -2.0480450479088144%
Revenue growth: -2.840528043485938%
Rule of 40 score: -4.888573091394752
Market cap: 11149373440 (Large Cap ($10B-$200B))
Debt to equity: 0.3608
Free cash flow (dilution adjusted): -65267727.93053546
Operating income: -173950795.94790158
Net income: -206512301.0130246
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 1208.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 106625302528 (Large Cap ($10B-$200B))
P/E ratio: 3.4314871075796525
Debt to equity: 0.5534
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1224.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4658801664 (Mid Cap ($2B-$10B))
Debt to equity: 0.539
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1224.HK (annual, report date 2025-12-31)
Altman Z-score: 0.4759731929146439 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.9245004386905453%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.9053032983890479%
Free cash flow margin: -46.88176137008468%
Revenue growth: 7.196419690599208%
Rule of 40 score: -39.685341679485475
Market cap: 4658801664 (Mid Cap ($2B-$10B))
Debt to equity: 0.539
Free cash flow (dilution adjusted): -32919794.344473008
Operating income: 24678406.16966581
Net income: -57122236.50385604
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1412.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 558600000 (Small Cap ($300M-$2B))
P/E ratio: 1.7644309418088338
Debt to equity: 0.0716
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1436.T (quarterly, report date 2025-10-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 16325357568 (Large Cap ($10B-$200B))
P/E ratio: 0.12182440603402825
Debt to equity: 1.0395
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1599.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1416103424 (Small Cap ($300M-$2B))
P/E ratio: 0.37099789670483757
Debt to equity: 0.7345999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1786.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 47079432192 (Large Cap ($10B-$200B))
P/E ratio: 0.089170178967657
Debt to equity: 0.0955
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1921.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 57931800576 (Large Cap ($10B-$200B))
P/E ratio: 0.07326749136054471
Debt to equity: 0.2139
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2307.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 133097600 (Micro Cap ($50M-$300M))
Debt to equity: 0.5499
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2307.HK (annual, report date 2025-12-31)
Altman Z-score: 1.7213408106932124 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.393782146915457%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.0234376725794694%
Free cash flow margin: 1.7447131999485603%
Revenue growth: -3.867906191564605%
Rule of 40 score: -2.123192991616045
Market cap: 133097600 (Micro Cap ($50M-$300M))
Debt to equity: 0.5499
Free cash flow (dilution adjusted): 8265809.768637531
Operating income: -8796143.958868895
Net income: -13802570.694087403
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 2477.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14057832448 (Large Cap ($10B-$200B))
P/E ratio: 0.1117647575395047
Debt to equity: 0
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 2721.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1409521792 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2936.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13989244928 (Large Cap ($10B-$200B))
P/E ratio: 0.3869696305721384
Debt to equity: 0.5268999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3286.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3317923840 (Mid Cap ($2B-$10B))
P/E ratio: 0.12085552135939097
Debt to equity: 7.4041999999999994
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3909.T (quarterly, report date 2026-03-31)
Altman Z-score: 3.742518865151398 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 50.78157729131342%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.288181170648735%
Free cash flow margin: -6.099546168278632%
Rule of 40 score: -6.099546168278632
Market cap: 1757403520 (Small Cap ($300M-$2B))
P/E ratio: 0.04736534214626998
Debt to equity: 0.3528
Free cash flow (dilution adjusted): -1244538.2882882883
Operating income: 791860.6106106106
Net income: 5323004.2542542545
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 3989.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 33551638528 (Large Cap ($10B-$200B))
P/E ratio: 0.12182650060702786
Debt to equity: 0.0611
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 411A.T (annual, report date 2026-01-31)
Altman Z-score: 1.2523798764790957 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 17.00721189679743%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.271082747614026%
Free cash flow margin: -362.02200049336767%
Revenue growth: 66.7984594927065%
Rule of 40 score: -295.22354100066116
Market cap: 1368999936 (Small Cap ($300M-$2B))
P/E ratio: 0.04508724064235036
Debt to equity: 6.4376999999999995
Free cash flow (dilution adjusted): -35740265.08226691
Operating income: 2281457.2995560197
Net income: 1404028.4669626534
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for 4679.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1911322880 (Small Cap ($300M-$2B))
Debt to equity: 0.4265
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4679.T (annual, report date 2026-03-31)
Altman Z-score: 1.4646939874583031 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -27.260078492225485%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.624448775902349%
Free cash flow margin: -1.8465982694679928%
Revenue growth: -12.738374344670364%
Rule of 40 score: -14.584972614138357
Market cap: 1911322880 (Small Cap ($300M-$2B))
Debt to equity: 0.4265
Free cash flow (dilution adjusted): -586367.6176176176
Operating income: 237550.05005005005
Net income: -1003966.4664664664
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 5341.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1438463488 (Small Cap ($300M-$2B))
Debt to equity: 0.45899999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5363.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 30746777600 (Large Cap ($10B-$200B))
P/E ratio: 0.04100514668075818
Debt to equity: 0.0623
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5449.T (annual, report date 2026-03-31)
Altman Z-score: 3.2190541955264163 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.615432991635746%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.28936703077274534%
Free cash flow margin: 9.275889627323968%
Revenue growth: -23.5418275762191%
Rule of 40 score: -14.26593794889513
Market cap: 79254208512 (Large Cap ($10B-$200B))
Debt to equity: 0.14550000000000002
Free cash flow (dilution adjusted): 55186436.43643644
Operating income: -2139639.6396396398
Net income: -130980980.98098098
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 5449.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 79254208512 (Large Cap ($10B-$200B))
Debt to equity: 0.14550000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5644.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 22042327040 (Large Cap ($10B-$200B))
P/E ratio: 0.033099418345319986
Debt to equity: 0.14880000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6648.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 27850928128 (Large Cap ($10B-$200B))
P/E ratio: 0.0661088677143723
Debt to equity: 0.115
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7075.T (annual, report date 2026-03-31)
Altman Z-score: 4.267223039986254 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.916135058004535%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 27.15740324466363%
Free cash flow margin: 3.412786633243344%
Revenue growth: 6.7045968460571554%
Rule of 40 score: 10.1173834793005
Market cap: 6138421760 (Mid Cap ($2B-$10B))
P/E ratio: 0.07170731048042465
Debt to equity: 0.9531999999999999
Free cash flow (dilution adjusted): 2567348.5985985985
Operating income: 5506287.5375375375
Net income: 3192792.792792793
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 7075.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6138421760 (Mid Cap ($2B-$10B))
P/E ratio: 0.07170731048042465
Debt to equity: 0.9531999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8022.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 273755455488 (Mega Cap (>= $200B))
P/E ratio: 0.087936201132731
Debt to equity: 0.1441
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8282.T (quarterly, report date 2025-09-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 291020472320 (Mega Cap (>= $200B))
P/E ratio: 0.11629604847820556
Debt to equity: 0.2429
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9024.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 904872919040 (Mega Cap (>= $200B))
P/E ratio: 0.18117196300580427
Debt to equity: 1.1344
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9778.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3284367872 (Mid Cap ($2B-$10B))
P/E ratio: 0.506342445471982
Debt to equity: 0.507
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ACCS (quarterly, report date 2026-03-31)
Altman Z-score: 1.5143060647741886 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 1201120
ROCI (R&D adjusted): -2.366915182637169%
Rosenberg metric: -0.8661290322580645
Free cash flow margin: 9.367373756335647%
Revenue growth: -8.139334367994481%
Rule of 40 score: 1.2280393883411662
Market cap: 25544508 (Nano Cap (< $50M))
Debt to equity: 0.09960000000000001
Free cash flow (dilution adjusted): 499000
Operating income: -718000
Net income: -611000
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for AGFB.BR (quarterly, report date 2026-03-31)
Altman Z-score: 1.6035149184245123 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -450%
Capitalized R&D asset: 37575524.00270453
ROCI (R&D adjusted): -0.3534019941701064%
Rosenberg metric: -1.6498084291187745
Free cash flow margin: -18.64406779661017%
Revenue growth: -24.648786717752238%
Rule of 40 score: -43.2928545143624
Market cap: 64405340 (Micro Cap ($50M-$300M))
Debt to equity: 0.7968000000000001
Free cash flow (dilution adjusted): -50574712.64367816
Operating income: -4597701.149425288
Net income: -13793103.448275862
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AGM (quarterly, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.4433475187548668%
Capitalized R&D asset: 0
Free cash flow margin: 81.60183276059566%
Revenue growth: 1.5087951033924634%
Rule of 40 score: 83.11062786398811
Market cap: 2272973568 (Mid Cap ($2B-$10B))
P/E ratio: 8.465745538284398
Debt to equity: 20.1266
Free cash flow (dilution adjusted): 89048000
Net income: 59123000
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ALERS.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 208413376 (Micro Cap ($50M-$300M))
P/E ratio: 60.9511889862328
Debt to equity: 0.087
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ALHGR.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 71631392 (Micro Cap ($50M-$300M))
Debt to equity: 0.536
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ALHGR.PA (annual, report date 2025-12-31)
Altman Z-score: 0.7822061849788372 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.89999781987835%
Capitalized R&D asset: -699182.8431372549
ROCI (R&D adjusted): -15.752980931682249%
Free cash flow margin: -107.4337964612279%
Revenue growth: 43.58056265984654%
Rule of 40 score: -63.85323380138136
Market cap: 71631392 (Micro Cap ($50M-$300M))
Debt to equity: 0.536
Free cash flow (dilution adjusted): -21287058.823529415
Operating income: -15657647.05882353
Net income: -17430588.23529412
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AOMR (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.872301500182949%
Capitalized R&D asset: 0
Revenue growth: -113.19319679003475%
Rule of 40 score: -113.19319679003475
Market cap: 219248912 (Micro Cap ($50M-$300M))
P/E ratio: 12.555555555555555
Debt to equity: 9.4127
Free cash flow (dilution adjusted): -144138000
Net income: -7379000
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for ASG.V (quarterly, report date 2026-03-31)
Altman Z-score: -1.3955176335174209 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 175093.88820038858
ROCI (R&D adjusted): -2.7436248990769214%
Rosenberg metric: -3.9710685027881154
Free cash flow margin: -1.082803725171236%
Revenue growth: -12.95491931225841%
Rule of 40 score: -14.037723037429645
Market cap: 16789824 (Nano Cap (< $50M))
Debt to equity: 0.9765
Free cash flow (dilution adjusted): -34556.11510791367
Operating income: -119281.29496402878
Net income: -145938.1294964029
Long score: 1 | Short score: 8
Recommendation: Short